Ghent University Academic Bibliography

Journal Article
A1
open access

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2023) CANCER IMMUNOLOGY IMMUNOTHERAPY. 72(2). p.475-491

Add to list

Journal Article
A2
open access

Pushing the boundaries : concurrent Hodgkin lymphoma and breast cancer treatment with preservation of pregnancy : a case report

Charlotte Lejeune, Daan Dierickx, Hans Wildiers, Lore Lannoo, Kristel Van Calsteren, Vincent Vandecaveye, Björn Menten (UGent) , Joris Vermeesch and Frédéric Amant

(2022) GYNECOLOGIC ONCOLOGY REPORTS. 39.

Add to list

2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188

Add to list

Journal Article
A1
open access

Association of chemotherapy timing in pregnancy with congenital malformation

Mathilde van Gerwen, Charlotte Maggen, Elyce Cardonick, Emma J. Verwaaijen, Marry van den Heuvel-eibrink, Roman G. Shmakov, Ingrid Boere, Mina M. Gziri, Petronella B. Ottevanger, Christianne A. R. Lok, et al.

(2021) JAMA NETWORK OPEN. 4(6).

Add to list

Journal Article
A1
open access

The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers

Stijn Moens, Peihua Zhao, Maria Francesca Baietti, Oliviero Marinelli, Delphi Van Haver (UGent) , Francis Impens (UGent) , Giuseppe Floris, Elisabetta Marangoni, Patrick Neven, Daniela Annibali, et al.

(2021) SCIENTIFIC REPORTS. 11.

Add to list

Journal Article
A1
open access

The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited : a European Network for Individualized Treatment of Endometrial Cancer collaboration study

Willem Jan van Weelden, Casper Reijnen, Heidi V.N. Küsters-Vandevelde, Johan Bulten, Peter Bult, Samuel Leung, Nicole C.M. Visser, Maria Santacana, Peter Bronsert, Marc Hirschfeld, et al.

(2021) HUMAN PATHOLOGY. 109. p.80-91

Add to list

Journal Article
A1
open access

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model : a development and validation study.

Casper Reijnen, Evangelia Gogou, Nicole C M Visser, Hilde Engerud, Jordache Ramjith, Louis J M van der Putten, Koen Van de Vijver (UGent) , Maria Santacana, Peter Bronsert, Johan Bulten, et al.

(2020) PLOS MEDICINE. 17(5). p.e1003111-e1003111

Add to list

Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo, Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Kathia De Man (UGent) , Eline Naert (UGent) , Jo Van Dorpe (UGent) , Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , et al.

(2020) GYNECOLOGIC ONCOLOGY. 159(2). p.335-343

Add to list

Poor outcome in hypoxic endometrial carcinoma is related to vascular density

Casper Reijnen, Willem Jan van Weelden, Martijn SJP Arts, Johan P Peters, Paul F Rijken, Koen Van de Vijver (UGent) , Maria Santacana, Peter Bronsert, Johan Bulten, Marc Hirschfeld, et al.

(2019) BRITISH JOURNAL OF CANCER. 120(11). p.1037-1044

Add to list

Treatment of ovarian cancer with intraperitoneal platinum : heating up the debate

Emiel De Jaeghere (UGent) , Félix Gremonprez, Philippe Tummers (UGent) , Wouter Willaert (UGent) , Wim Ceelen (UGent) , Frédéric Amant and Hannelore Denys (UGent)

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(33). p.3169-3170

Academic Bibliography

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Pushing the boundaries : concurrent Hodgkin lymphoma and breast cancer treatment with preservation of pregnancy : a case report

2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial

Association of chemotherapy timing in pregnancy with congenital malformation

The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers

The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited : a European Network for Individualized Treatment of Endometrial Cancer collaboration study

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model : a development and validation study.

Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Poor outcome in hypoxic endometrial carcinoma is related to vascular density

Treatment of ovarian cancer with intraperitoneal platinum : heating up the debate

Contents

Support

Contact